New Resuscitation Device Provides Continuous Oxygen Delivery During CPR

"No pause should be your cause," or so French medical device manufacturer Vygon believes. In March, JEMS Editor-in-Chief A.J. Heightman and I traveled to Paris to attend a one-day emergency symposium titled, Alveolar Ventilation by Continuous Chest Compression: b-card, a new device designed for use during cardiac arrest management. During the symposium, current cardiac arrest guidelines, the Boussignac Cardiac Arrest Resuscitation Device (b-card) and how the two are interconnected were discussed. The b-card is available and in use in Europe and Canada; however, it's not available or approved for sale in the United States. Vygon has applied to the Food and Drug Administration (FDA) for approval for use in the U.S. The b-card creates a virtual valve that ensures dynamic alveolar ventilation without the need to interrupt chest compressions. The resuscitation symposium started with a review of the current International Liaison Council on Resuscitation (ILCOR) guidelines on cardiac arrest and a comparison of the guidelines put forth by the American Heart Association and the European Resuscitation Council. It was emphasized during the first half of the symposium, and acknowledged by resuscitation experts present from multiple countries, that early citizen response and initiation of CPR along with high quality, consistent CPR by emergency crews are paramount to patient survival.
Source: JEMS Patient Care - Category: Emergency Medicine Authors: Tags: Patient Care Source Type: news